Concepedia

A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A Gynecologic Oncology Group Study

Robert L. Coleman, William E. Brady, D. Scott McMeekin, Peter G. Rose, John T. Soper, Samuel S. Lentz, James Hoffman, Mark S. Shahin

Gynecologic Oncology · 2011 · 117 citations · 33 references

DOIFull text

Open access

Concepts

References

33

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

William P. McGuire, William J. Hoskins, Mark F. Brady et al. · New England Journal of Medicine · 1996 · 2.9K citations · Full text

, , +16

Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.

Neil Desai, Vuong Trieu, Zhiwen Yao et al. · Clinical Cancer Research · 2006 · 1.2K citations

, , +14

The microtubule-affecting drug paclitaxel has antiangiogenic activity.

Dorina Belotti, Veronica Vergani, Teresa Drudis et al. · PubMed · 1996 · 646 citations

, , +13

Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol.

Nancy Klauber, Sareh Parangi, Evelyn Flynn et al. · PubMed · 1997 · 527 citations

, , +15

SPARC Expression Correlates with Tumor Response to Albumin-Bound Paclitaxel in Head and Neck Cancer Patients

Neil Desai, Vuong Trieu, B Damascelli et al. · Translational Oncology · 2009 · 395 citations · Full text

, , +8